Park Medi World Limited (NSE: PARKHOSPS) wins three honours at Healthcare Pioneers of Delhi 2026, showcasing its leadership in advanced medical technology an.
Park Medi World Limited (PARKHOSPS) announces Q1 FY’27 unaudited results with 19% revenue growth, 20% EBITDA, and 35% net profit surge.
Park Medi World Limited announces record Q4 & 12M FY’26 results, with 27% YoY net profit growth and 21% revenue increase.